A Study of 28431754 (Canagliflozin) on Gastrointestinal Glucose Absorption and Metabolism in Healthy Volunteers
Clinical trial NCT01173549 · COMPLETED
Trial details
- NCT number
- NCT01173549
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.